T. Pelat, M. Hust, M. Hale, M. P. Lefranc, S. Dübel et al., Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity, BMC Biotechnology, vol.9, issue.1, p.60, 2009.
DOI : 10.1186/1472-6750-9-60
URL : https://hal.archives-ouvertes.fr/hal-00410069

T. Pelat, M. Hust, E. Laffly, F. Condemine, C. Bottex et al., High-Affinity, Human Antibody-Like Antibody Fragment (Single-Chain Variable Fragment) Neutralizing the Lethal Factor (LF) of Bacillus anthracis by Inhibiting Protective Antigen-LF Complex Formation, Antimicrobial Agents and Chemotherapy, vol.51, issue.8, pp.2758-2764, 2007.
DOI : 10.1128/AAC.01528-06
URL : http://aac.asm.org/content/51/8/2758.full.pdf

E. Laffly, L. Danjou, F. Condemine, D. Vidal, E. Drouet et al., Selection of a Macaque Fab with Framework Regions Like Those in Humans, High Affinity, and Ability To Neutralize the Protective Antigen (PA) of Bacillus anthracis by Binding to the Segment of PA between Residues 686 and 694, Antimicrobial Agents and Chemotherapy, vol.49, issue.8, pp.3414-3420, 2005.
DOI : 10.1128/AAC.49.8.3414-3420.2005

B. Hülseweh, T. Rülker, T. Pelat, C. Langermann, A. Frenzel et al., Human-like antibodies neutralizing Western equine encephalitis virus, mAbs, vol.22, issue.3, pp.717-726, 2014.
DOI : 10.1007/978-1-62703-586-6_12

J. W. Froude, T. Pelat, S. Miethe, S. E. Zak, A. Z. Wec et al., Generation and characterization of protective antibodies to Marburg virus, mAbs, vol.13, issue.4, pp.696-703
DOI : 10.1073/pnas.94.26.14764
URL : http://europepmc.org/articles/pmc5419075?pdf=render

J. Sobel, Y. Botulism-sugawara, and T. Matsumura, Uptake of botulinum neurotoxin in the intestine, Clin. Infect. Dis. Curr. Top. Microbiol. Immunol, vol.41, issue.364, pp.1167-1173, 2005.

R. G. Hibbs, J. T. Weber, A. Corwin, B. M. Allos, M. S. Rehim et al., Experience with the Use of an Investigational F(ab')2 Heptavalent Botulism Immune Globulin of Equine Origin During an Outbreak of Type E Botulism in Egypt, Clinical Infectious Diseases, vol.23, issue.2, pp.337-340, 1996.
DOI : 10.1093/clinids/23.2.337

K. Jalava, K. Selby, A. Pihlajasaari, E. Kolho, E. Dahlsten et al., Two cases of food-borne botulism in Finland caused by conserved olives, Euro Surveill, vol.16, 2011.
DOI : 10.2807/ese.16.49.20034-en
URL : http://www.eurosurveillance.org/deliver/fulltext/eurosurveillance/16/49/art20034-en.pdf?itemId=/content/10.2807/ese.16.49.20034-en&mimeType=pdf&containerItemId=content/eurosurveillance

J. M. Pingeon, C. Vanbockstael, M. R. Popoff, L. A. King, B. Deschamps et al., Mazuet, C.; et al. Two outbreaks of botulism associated with consumption of green olive paste, Euro Surveill, vol.16, 2011.

J. R. Barash and S. S. Arnon, A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins, The Journal of Infectious Diseases, vol.285, issue.2, pp.183-191
DOI : 10.1001/jama.285.8.1059
URL : https://academic.oup.com/jid/article-pdf/209/2/183/13804422/jit449.pdf

N. Dover, J. R. Barash, K. K. Hill, G. Xie, and S. S. Arnon, Molecular Characterization of a Novel Botulinum Neurotoxin Type H Gene, The Journal of Infectious Diseases, vol.235, issue.2, pp.192-202, 2014.
DOI : 10.1111/j.1574-6968.2004.tb09561.x
URL : https://academic.oup.com/jid/article-pdf/209/2/192/13804460/jit450.pdf

S. E. Maslanka, C. Lúquez, J. K. Dykes, W. H. Tepp, C. L. Pier et al., A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin, Journal of Infectious Diseases, vol.32, issue.3, pp.379-385, 2016.
DOI : 10.1093/infdis/150.3.407

S. Zhang, G. Masuyer, J. Zhang, Y. Shen, D. Lundin et al., Identification and characterization of a novel botulinum neurotoxin, Nature Communications, vol.7, pp.2017-14130
DOI : 10.1371/journal.ppat.1002008

M. J. Mansfield, J. B. Adams, and A. C. Doxey, Botulinum neurotoxin homologs in non-Clostridium species, FEBS Lett, vol.2015, issue.589, pp.342-348
DOI : 10.1016/j.febslet.2014.12.018
URL : http://onlinelibrary.wiley.com/doi/10.1016/j.febslet.2014.12.018/pdf

D. M. Gill, Bacterial toxins: A table of lethal amounts, Microbiol. Rev, vol.46, pp.86-94, 1982.

A. Fischer, C. Garcia-rodriguez, I. Geren, J. Lou, J. D. Marks et al., Molecular Architecture of Botulinum Neurotoxin E Revealed by Single Particle Electron Microscopy, Journal of Biological Chemistry, vol.19, issue.7, pp.3997-4003, 2008.
DOI : 10.1111/j.1471-4159.2004.02844.x
URL : http://www.jbc.org/content/283/7/3997.full.pdf

S. S. Arnon, R. Schechter, T. V. Inglesby, D. A. Henderson, J. G. Bartlett et al., Botulinum Toxin as a Biological Weapon, JAMA, vol.285, issue.8, pp.1059-1070, 2001.
DOI : 10.1001/jama.285.8.1059

J. W. Froude, B. Stiles, T. Pelat, and P. Thullier, Antibodies for biodefense, mAbs, vol.2, issue.6, pp.517-527, 2011.
DOI : 10.4161/mabs.2.3.11416
URL : http://www.tandfonline.com/doi/pdf/10.4161/mabs.3.6.17621?needAccess=true

G. Bozheyeva, Y. Kunakbayev, and D. Yeleukenov, Former Soviet Biological Weapons Facilities in Kazakhstan: Past, Present, and Future, Monterey Institute of International Studies, 1999.

W. J. Broad, Sowing Death: A Special Report; How Japan Germ Terror Alerted World. The New York Times Available online: http://www.nytimes.com/1998/05/26/world/sowing-death-a-special- report-how-japan-germ-terror-alerted-world, 1998.

L. M. Wein and Y. Liu, Analyzing a bioterror attack on the food supply: The case of botulinum toxin in milk, Proc. Natl. Acad. Sci. USA 2005, pp.9984-9989
DOI : 10.1056/NEJM199605163342001

C. Montecucco, How do tetanus and botulinum toxins bind to neuronal membranes?, Trends in Biochemical Sciences, vol.11, issue.8, pp.314-317, 1986.
DOI : 10.1016/0968-0004(86)90282-3

. Montal-botulinum-neurotoxin, Botulinum Neurotoxin: A Marvel of Protein Design, Annual Review of Biochemistry, vol.79, issue.1, pp.591-617, 2010.
DOI : 10.1146/annurev.biochem.051908.125345

C. Verderio, O. Rossetto, C. Grumelli, C. Frassoni, C. Montecucco et al., Entering neurons: botulinum toxins and synaptic vesicle recycling, EMBO reports, vol.10, issue.10, pp.995-999, 2006.
DOI : 10.1074/jbc.M205258200
URL : http://embor.embopress.org/content/embor/7/10/995.full.pdf

O. Rossetto, M. Pirazzini, and C. Montecucco, Botulinum neurotoxins: genetic, structural and mechanistic insights, Nature Reviews Microbiology, vol.344, issue.8, pp.535-549, 2014.
DOI : 10.1126/science.1253823

M. Pirazzini, O. Rossetto, R. Eleopra, and C. Montecucco, Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology, Pharmacological Reviews, vol.69, issue.2, pp.200-235
DOI : 10.1124/pr.116.012658
URL : http://pharmrev.aspetjournals.org/content/pharmrev/69/2/200.full.pdf

T. Matsumura, Y. Jin, Y. Kabumoto, Y. Takegahara, K. Oguma et al., The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption, Cellular Microbiology, vol.248, issue.0, pp.355-364, 2008.
DOI : 10.1046/j.1462-5822.2000.00025.x
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1462-5822.2007.01048.x/pdf

Y. Jin, Y. Takegahara, Y. Sugawara, T. Matsumura, and Y. Fujinaga, Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins - differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C, Microbiology, vol.51, issue.10, pp.35-45, 2009.
DOI : 10.1016/S0006-291X(05)80328-6

K. Lee, X. Zhong, S. Gu, A. M. Kruel, M. B. Dorner et al., Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex, Science, vol.64, issue.5, pp.1405-1410, 2014.
DOI : 10.1006/bbrc.2002.6689

Y. Sugawara, T. Matsumura, Y. Takegahara, Y. Jin, Y. Tsukasaki et al., Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin, The Journal of Cell Biology, vol.16, issue.4, pp.691-700, 2010.
DOI : 10.1083/jcb.200910119.dv

T. Matsumura, Y. Sugawara, M. Yutani, S. Amatsu, H. Yagita et al., Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity, Nature Communications, vol.10, issue.1, pp.2015-6255
DOI : 10.1074/jbc.M410599200
URL : http://www.nature.com/articles/ncomms7255.pdf

C. Connan, C. Varela-chavez, C. Mazuet, J. Molgó, G. M. Haustant et al., Translocation and dissemination to target neurons of botulinum neurotoxin type B in the mouse intestinal wall, Cellular Microbiology, vol.20, issue.320, pp.282-301, 2016.
DOI : 10.3748/wjg.v20.i32.11273
URL : https://hal.archives-ouvertes.fr/pasteur-01780625

M. Pirazzini and O. Rossetto, Challenges in searching for therapeutics against Botulinum Neurotoxins, Expert Opinion on Drug Discovery, vol.364, issue.5, pp.497-510
DOI : 10.1016/j.tim.2010.02.001

S. S. Arnon, R. Schechter, S. E. Maslanka, N. P. Jewell, and C. L. Hatheway, Human Botulism Immune Globulin for the Treatment of Infant Botulism, New England Journal of Medicine, vol.354, issue.5, pp.462-471, 2006.
DOI : 10.1056/NEJMoa051926

R. E. Black and R. A. Gunn, Hypersensitivity reactions associated with botulinal antitoxin, The American Journal of Medicine, vol.69, issue.4, pp.567-570, 1980.
DOI : 10.1016/0002-9343(80)90469-6

C. Mayers, S. Veall, R. Bedford, and J. Holley, , and Fab Botulinum Antitoxins in Mice, Immunopharmacology and Immunotoxicology, vol.150, issue.3, pp.397-408, 2003.
DOI : 10.1093/infdis/150.3.407

K. A. Foster, Engineered toxins: New therapeutics, Toxicon, vol.54, issue.5, pp.587-592, 2009.
DOI : 10.1016/j.toxicon.2009.01.037

R. P. Fagan, K. P. Neil, R. Sasich, C. Luquez, H. Asaad et al., Initial Recovery and Rebound of Type F Intestinal Colonization Botulism After Administration of Investigational Heptavalent Botulinum Antitoxin, Clinical Infectious Diseases, vol.175, issue.3, pp.125-128, 2011.
DOI : 10.1093/infdis/175.3.633

J. M. Rusnak and L. A. Smith, Botulinum neurotoxin vaccines: Past history and recent developments. Hum. Vaccines, pp.794-805, 2009.
DOI : 10.4161/hv.9420
URL : https://www.tandfonline.com/doi/pdf/10.4161/hv.9420?needAccess=true

L. A. Smith, Botulism and vaccines for its prevention, Vaccine, vol.27, pp.33-39, 2009.
DOI : 10.1016/j.vaccine.2009.08.059

R. Kaji, New and emerging indications of botulinum toxin therapy, Parkinsonism & Related Disorders, vol.17, pp.25-27, 2011.
DOI : 10.1016/j.parkreldis.2011.06.017

J. O. Dolly, G. W. Lawrence, J. Meng, J. Wang, and S. V. Ovsepian, Neuro-exocytosis: botulinum toxins as inhibitory probes and versatile therapeutics???, Current Opinion in Pharmacology, vol.9, issue.3, pp.326-335, 2009.
DOI : 10.1016/j.coph.2009.03.004

D. Dressler, S. Paus, A. Seitzinger, B. Gebhardt, and A. Kupsch, Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia, Journal of Neurology, Neurosurgery & Psychiatry, vol.43, issue.Suppl 1, pp.1014-1019, 2013.
DOI : 10.2340/16501977-0796

T. J. Smith, J. Lou, I. N. Geren, C. M. Forsyth, R. Tsai et al., Sequence Variation within Botulinum Neurotoxin Serotypes Impacts Antibody Binding and Neutralization, Infection and Immunity, vol.73, issue.9, pp.5450-5457, 2005.
DOI : 10.1128/IAI.73.9.5450-5457.2005
URL : https://iai.asm.org/content/73/9/5450.full.pdf

A. Avril, J. Froude, J. Mathieu, T. Pelat, and P. Thullier, Isolation of Antibodies From Non-Human Primates for Clinical Use, Current Drug Discovery Technologies, vol.11, issue.1, pp.20-27, 2014.
DOI : 10.2174/15701638113109990030

T. Pelat, M. Hust, and P. Thullier, Obtention and Engineering of Non-Human Primate (NHP) Antibodies for Therapeutics, Mini-Reviews in Medicinal Chemistry, vol.9, issue.14, pp.1633-1638, 2009.
DOI : 10.2174/138955709791012283

S. P. Adekar, T. Takahashi, R. M. Jones, F. H. Saleem, D. M. Ancharski et al., Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain, PLoS ONE, vol.304, issue.8, p.3023, 2008.
DOI : 10.1371/journal.pone.0003023.t002

S. Chahboun, M. Hust, Y. Liu, T. Pelat, S. Miethe et al., Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin, BMC Biotechnology, vol.11, issue.1, p.113, 2011.
DOI : 10.1186/1472-6750-11-113

S. Miethe, C. Rasetti-escargueil, Y. Liu, S. Chahboun, T. Pelat et al., Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library, mAbs, vol.57, issue.2, pp.446-459, 2014.
DOI : 10.1038/2338

S. R. Kalb, J. Lou, C. Garcia-rodriguez, I. N. Geren, and T. Smith, J.; Moura, H.; Marks, J.D

J. L. Pirkle and J. Barr, Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies, PLoS ONE, vol.4, issue.5355, 2009.

A. Nowakowski, C. Wang, D. B. Powers, P. Amersdorfer, T. J. Smith et al.,

R. Blake, L. A. Smith, and J. D. Marks, Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody, Proc. Natl. Acad. Sci. USA 2002, pp.11346-11350

L. W. Cheng, L. H. Stanker, T. D. Henderson, J. Lou, and J. D. Marks, Antibody Protection against Botulinum Neurotoxin Intoxication in Mice, Infection and Immunity, vol.77, issue.10, pp.4305-4313, 2009.
DOI : 10.1128/IAI.00405-09
URL : http://iai.asm.org/content/77/10/4305.full.pdf

J. O. Conway, L. J. Sherwood, M. T. Collazo, J. A. Garza, and A. Hayhurst, Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents, PLoS ONE, vol.5, issue.1, p.881, 2010.
DOI : 10.1371/journal.pone.0008818.s003
URL : http://doi.org/10.1371/journal.pone.0008818

B. Z. Dolimbek, K. R. Aoki, L. E. Steward, J. Jankovic, and M. Z. Atassi, Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A, Molecular Immunology, vol.44, issue.5, pp.1029-1041, 2007.
DOI : 10.1016/j.molimm.2006.03.011

P. Amersdorfer, C. Wong, S. Chen, T. Smith, S. Deshpande et al., Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries, Infect. Immun, vol.65, pp.3743-3752, 1997.

A. Razai, C. Garcia-rodriguez, J. Lou, I. N. Geren, C. M. Forsyth et al., Molecular Evolution of Antibody Affinity for Sensitive Detection of Botulinum Neurotoxin Type A, Journal of Molecular Biology, vol.351, issue.1, pp.158-169, 2005.
DOI : 10.1016/j.jmb.2005.06.003

P. Amersdorfer, C. Wong, T. Smith, S. Chen, S. Deshpande et al., Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries, Vaccine, vol.20, issue.11-12, pp.1640-1648, 2002.
DOI : 10.1016/S0264-410X(01)00482-0

J. Dong, A. A. Thompson, Y. Fan, J. Lou, F. Conrad et al., A Single-Domain Llama Antibody Potently Inhibits the Enzymatic Activity of Botulinum Neurotoxin by Binding to the Non-Catalytic ??-Exosite Binding Region, Journal of Molecular Biology, vol.397, issue.4, pp.1106-1118, 2010.
DOI : 10.1016/j.jmb.2010.01.070

T. Takahashi, S. G. Joshi, F. Saleem, D. Ancharski, A. Singh et al., Localization of the sites and characterization of the mechanisms by which anti-light chain antibodies neutralize the actions of the botulinum holotoxin, Vaccine, vol.27, issue.19, pp.2616-2624, 2009.
DOI : 10.1016/j.vaccine.2009.02.051

S. R. Kalb, W. I. Santana, I. N. Geren, C. Garcia-rodriguez, J. Lou et al., Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies, BMC Biochemistry, vol.12, issue.1, p.58, 2011.
DOI : 10.1016/j.jmb.2006.09.084

C. Garcia-rodriguez, I. N. Geren, J. Lou, F. Conrad, C. Forsyth et al., Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin, Protein Engineering Design and Selection, vol.564, issue.1-2, pp.321-331, 2011.
DOI : 10.1016/S0014-5793(04)00309-6
URL : https://academic.oup.com/peds/article-pdf/24/3/321/4491727/gzq111.pdf

T. Kubota, T. Watanabe, N. Yokosawa, K. Tsuzuki, T. Indoh et al., Epitope regions in the heavy chain of Clostridium botulinum type E neurotoxin recognized by monoclonal antibodies, Appl. Environ. Microbiol, vol.63, pp.1214-1218, 1997.

M. Schütte, P. Thullier, T. Pelat, X. Wezler, P. Rosenstock et al., Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus, PLoS ONE, vol.202, issue.8, 2009.
DOI : 10.1371/journal.pone.0006625.t003

S. Chassagne, E. Laffly, E. Drouet, F. Hérodin, M. Lefranc et al., A high-affinity macaque antibody Fab with human-like framework regions obtained from a small phage display immune library, Molecular Immunology, vol.41, issue.5, pp.539-546, 2004.
DOI : 10.1016/j.molimm.2004.03.040

E. Laffly, T. Pelat, F. Cédrone, S. Blésa, H. Bedouelle et al., Improvement of an Antibody Neutralizing the Anthrax Toxin by Simultaneous Mutagenesis of Its Six Hypervariable Loops, Journal of Molecular Biology, vol.378, issue.5, pp.1094-1103, 2008.
DOI : 10.1016/j.jmb.2008.03.045

T. Kuwata, Y. Katsumata, K. Takaki, T. Miura, and T. Igarashi, Isolation of Potent Neutralizing Monoclonal Antibodies from an SIV-Infected Rhesus Macaque by Phage Display, AIDS Research and Human Retroviruses, vol.27, pp.487-500, 2011.
DOI : 10.1089/aid.2010.0191

R. G. Rasetti-escargueil, Y. Jones, D. Liu, and . Sesardic, Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve???hemidiaphragm: Improved precision with in-bred mice, Toxicon, vol.53, issue.5, pp.503-511, 2009.
DOI : 10.1016/j.toxicon.2009.01.019

C. Rasetti-escargueil, Y. Liu, P. Rigsby, R. G. Jones, and D. Sesardic, Phrenic nerve-hemidiaphragm as a highly sensitive replacement assay for determination of functional botulinum toxin antibodies, Toxicon, vol.57, issue.7-8, pp.1008-1016, 2011.
DOI : 10.1016/j.toxicon.2011.04.003

P. Thullier, S. Chahboun, and T. Pelat, ) immunoglobulin germline V regions and its implications for antibody engineering, mAbs, vol.2, issue.5, pp.528-538, 2010.
DOI : 10.1126/science.1139247
URL : http://www.tandfonline.com/doi/pdf/10.4161/mabs.2.5.12545?needAccess=true

P. Thullier, O. Huish, T. Pelat, and A. C. Martin, The Humanness of Macaque Antibody Sequences, Journal of Molecular Biology, vol.396, issue.5, pp.1439-1450, 2010.
DOI : 10.1016/j.jmb.2009.12.041
URL : http://acrmwww.biochem.ucl.ac.uk/publications/freepdf/macaque_submit.pdf

A. Avril, S. Miethe, M. R. Popoff, C. Mazuet, S. Chahboun et al., Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain, BMC Biotechnology, vol.53, issue.2, pp.15-86, 2015.
DOI : 10.1016/j.toxicon.2009.01.019
URL : https://hal.archives-ouvertes.fr/pasteur-01783510

C. Rasetti-escargueil, A. Avril, S. Chahboun, R. Tierney, N. Bak et al., Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B, mAbs, vol.295, issue.6, pp.1161-1177, 2015.
DOI : 10.1002/mds.20021
URL : https://hal.archives-ouvertes.fr/pasteur-01783494

S. Miethe, C. Rasetti-escargueil, A. Avril, Y. Liu, S. Chahboun et al., Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E, PLOS ONE, vol.384, issue.10, p.139905, 2015.
DOI : 10.1371/journal.pone.0139905.s001
URL : https://hal.archives-ouvertes.fr/pasteur-01325687

Y. Derman, K. Selby, S. Miethe, A. Frenzel, Y. Liu et al., Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody, Toxins, vol.40, issue.9, p.257, 2016.
DOI : 10.1016/j.toxicon.2006.05.007
URL : http://www.mdpi.com/2072-6651/8/9/257/pdf

V. Ahmadzadeh, S. Farajnia, M. A. Feizi, and R. A. Nejad, Antibody Humanization Methods for Development of Therapeutic Applications, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, vol.33, issue.2, pp.67-73, 2014.
DOI : 10.1089/mab.2013.0080

T. Pelat and P. Thullier, Non-human primate immune libraries combined with germline humanization, mAbs, vol.146, issue.4, pp.377-381, 2009.
DOI : 10.1016/j.critrevonc.2007.04.011
URL : http://www.tandfonline.com/doi/pdf/10.4161/mabs.1.4.8635?needAccess=true

P. Tan, D. A. Mitchell, T. N. Buss, M. A. Holmes, C. Anasetti et al., "Superhumanized" Antibodies: Reduction of Immunogenic Potential by Complementarity-Determining Region Grafting with Human Germline Sequences: Application to an Anti-CD28, The Journal of Immunology, vol.169, issue.2, pp.1119-1125, 2002.
DOI : 10.4049/jimmunol.169.2.1119
URL : http://www.jimmunol.org/content/jimmunol/169/2/1119.full.pdf

G. T. Williams, C. J. Jolly, J. Köhler, and M. S. Neuberger, The Contribution of Somatic Hypermutation to the Diversity of Serum Immunoglobulin, Immunity, vol.13, issue.3, pp.409-417, 2000.
DOI : 10.1016/S1074-7613(00)00040-6

C. Pommié, S. Levadoux, R. Sabatier, G. Lefranc, and M. Lefranc, IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties, Journal of Molecular Recognition, vol.17, issue.1, pp.17-32, 2004.
DOI : 10.1002/jmr.647

I. Tool, Available online: http://www.imgt.org (accessed on 28, 2017.

M. Hust, T. Meyer, B. Voedisch, T. Rülker, H. Thie et al., A human scFv antibody generation pipeline for proteome research, Journal of Biotechnology, vol.152, issue.4, pp.159-170, 2011.
DOI : 10.1016/j.jbiotec.2010.09.945

N. I. Pathan, A. Zou, P. Chu, D. Wynne, B. Leigh et al., IDEC-152), an anti-CD23 antibody, induces apoptosis in vitro and in vivo in CLL cells, Proc. Am. Assoc. Cancer Res, p.45, 2004.

L. J. Rosenwasser, W. W. Busse, R. G. Lizambri, T. A. Olejnik, and M. C. Totoritis, Allergic asthma and an anti-CD23 mAb (IDEC-152) Results of a phase I, single-dose, dose-escalating clinical trial, Journal of Allergy and Clinical Immunology, vol.112, issue.3, pp.563-570, 2003.
DOI : 10.1016/S0091-6749(03)01861-X

N. R. Whitelegg and A. R. Rees, WAM: an improved algorithm for modelling antibodies on the WEB, Protein Engineering, Design and Selection, vol.13, issue.12, pp.819-824, 2000.
DOI : 10.1084/jem.132.2.211
URL : https://academic.oup.com/peds/article-pdf/13/12/819/18544068/130819.pdf

S. Miethe, C. Mazuet, Y. Liu, R. Tierney, C. Rasetti-escargueil et al., et al. Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B, PLoS ONE, issue.11, p.161446, 2016.

E. Diamant, B. Lachmi, A. Keren, A. Barnea, H. Marcuk et al., Evaluating the Synergistic Neutralizing Effect of Anti-Botulinum Oligoclonal Antibody Preparations, PLoS ONE, vol.7, issue.1, p.87089
DOI : 10.1371/journal.pone.0087089.s004
URL : https://doi.org/10.1371/journal.pone.0087089

H. Bakherad, S. L. Gargari, and I. Rasooli,

L. S. Ardakani and H. Zare, In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH), Mol. Biotechnol, vol.55, pp.159-167, 2013.

. Hbat-package and . Insert, Available online: https://www.fda.gov, UCM345147.pdf (accessed on 28, 2017.